AstraZeneca

AstraZeneca logo
🇬🇧United Kingdom
Ownership
Public
Employees
89.9K
Market Cap
$270.3B
Website
http://www.astrazeneca.co.uk
Introduction

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in Russia

Recruiting
Conditions
First Posted Date
2024-08-22
Last Posted Date
2024-11-28
Lead Sponsor
AstraZeneca
Target Recruit Count
110
Registration Number
NCT06566885
Locations
🇷🇺

Research Site, Orenburg, Russian Federation

Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma

First Posted Date
2024-08-20
Last Posted Date
2024-12-09
Lead Sponsor
AstraZeneca
Target Recruit Count
100
Registration Number
NCT06563102
Locations
🇺🇸

Research Site, Waco, Texas, United States

A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants

Phase 1
Completed
Conditions
Interventions
First Posted Date
2024-08-15
Last Posted Date
2024-10-15
Lead Sponsor
AstraZeneca
Target Recruit Count
28
Registration Number
NCT06554821
Locations
🇩🇪

Research Site, Berlin, Germany

A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2024-08-15
Last Posted Date
2024-12-17
Lead Sponsor
AstraZeneca
Target Recruit Count
31
Registration Number
NCT06555822
Locations
🇺🇸

Research Site, Brooklyn, Maryland, United States

AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database

Not yet recruiting
Conditions
First Posted Date
2024-08-12
Last Posted Date
2024-08-12
Lead Sponsor
AstraZeneca
Target Recruit Count
120
Registration Number
NCT06548152

A Study of AZD0486 Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

First Posted Date
2024-08-12
Last Posted Date
2024-12-18
Lead Sponsor
AstraZeneca
Target Recruit Count
1015
Registration Number
NCT06549595
Locations
🇬🇧

Research Site, London, United Kingdom

Imjudo & Imfinzi PMS

Not yet recruiting
Conditions
First Posted Date
2024-08-09
Last Posted Date
2024-08-09
Lead Sponsor
AstraZeneca
Target Recruit Count
246
Registration Number
NCT06544629
© Copyright 2024. All Rights Reserved by MedPath